No Data
J.P. Morgan Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $40
Option Care Health Is Maintained at Overweight by JP Morgan
Investing in Option Care Health (NASDAQ:OPCH) Five Years Ago Would Have Delivered You a 72% Gain
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $35
This Logitech International Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday
Jefferies Upgrades Option Care Health to Buy, Raises Price Target to $35